AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD

This article originally appeared here.
Share this content:
AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD
AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD

TUESDAY, Nov. 15, 2016 (HealthDay News) -- Ticagrelor is not superior to clopidogrel for reduction of cardiovascular events in patients with peripheral artery disease, according to a study published online Nov. 13 in the New England Journal of Medicine to coincide with the annual meeting of the American Heart Association, held from Nov. 12 to 16 in New Orleans.

William R. Hiatt, M.D., from the University of Colorado School of Medicine in Aurora, and colleagues compared clopidogrel with ticagrelor in patients with peripheral artery disease. A total of 13,885 patients with symptomatic peripheral artery disease with an ankle brachial index of 0.80 or less or who had undergone previous revascularization of the lower limbs were randomized to monotherapy with ticagrelor or clopidogrel.

The researchers found that the primary efficacy end point (composite of adjudicated cardiovascular death, myocardial infarction, or ischemic stroke) occurred in 10.8 and 10.6 percent of patients receiving ticagrelor and clopidogrel, respectively (hazard ratio, 1.02; 95 percent confidence interval, 0.92 to 1.13). Acute limb ischemia occurred in 1.7 percent of patients in each group (hazard ratio, 1.03; 95 percent confidence interval, 0.79 to 1.33) and major bleeding occurred in 1.6 percent of each group (hazard ratio, 1.10; 95 percent confidence interval, 0.84 to 1.43).

"In patients with symptomatic peripheral artery disease, ticagrelor was not shown to be superior to clopidogrel for the reduction of cardiovascular events," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Astra Zeneca, which manufactures ticagrelor and funded the study.

Abstract
Full Text
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

RSNA: Sleep Deprivation Appears to Affect Heart Function

RSNA: Sleep Deprivation Appears to Affect Heart Function

Small study finds lack of sleep affects blood pressure, heart rate in healthy volunteers

Three Low-Carb Meals a Day Can Lower Insulin Resistance

Three Low-Carb Meals a Day Can Lower Insulin ...

However, pre-meal exercising not helpful in reducing evening blood glucose levels

Augmented Reality, Gaming May Help Relieve Phantom Limb Pain

Augmented Reality, Gaming May Help Relieve Phantom Limb ...

Study finds exercising virtual limb can cut pain by as much as half

is free, fast, and customized just for you!

Already a member?

Sign In Now »